Jane Street’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.35M Buy
95,420
+37,364
+64% +$653K ﹤0.01% 4783
2025
Q4
$982K Sell
58,056
-12,888
-18% -$227K ﹤0.01% 6159
2025
Q3
$1.54M Buy
+70,944
New +$1.18M ﹤0.01% 5424
2025
Q2
Sell
-95,919
Closed -$1.25M 9949
2025
Q1
$1.25M Buy
95,919
+31,596
+49% +$477K ﹤0.01% 5159
2024
Q4
$857K Buy
64,323
+49,317
+329% +$500K ﹤0.01% 5676
2024
Q3
$90K Buy
+15,006
New +$63.4K ﹤0.01% 9029
2024
Q2
Sell
-23,078
Closed -$86.5K 9560
2024
Q1
$86.5K Buy
23,078
+4,650
+25% +$20.3K ﹤0.01% 8579
2023
Q4
$80.7K Sell
18,428
-46,782
-72% -$188K ﹤0.01% 8660
2023
Q3
$272K Buy
+65,210
New +$252K ﹤0.01% 7203
2023
Q2
Sell
-15,889
Closed -$61.2K 8890
2023
Q1
$61.2K Buy
15,889
+694
+5% +$2.53K ﹤0.01% 8401
2022
Q4
$42.9K Buy
+15,195
New +$40.9K ﹤0.01% 8416
2021
Q3
Sell
-11,837
Closed -$73K 10122
2021
Q2
$73K Buy
+11,837
New +$87.7K ﹤0.01% 9395
2020
Q3
Sell
-22,070
Closed -$121K 7321
2020
Q2
$121K Buy
+22,070
New +$110K ﹤0.01% 6640

Other funds holding ETON

Jane Street's ETON Position: Q1 2026 in Review

Jane Street increased its Eton Pharmaceutcials (ETON) stake by 64% in Q1 2026, buying an estimated $653K and bringing the position to 95,420 shares worth $2.35M. The position accounts for ﹤0.01% of the portfolio, ranked #4783.

Jane Street first reported a position in ETON in Q2 2020 and has held it in 13 quarters since. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Jane Street held 95,420 shares of Eton Pharmaceutcials worth $2.35M as of Q1 2026.
  • Jane Street bought 37,364 Eton Pharmaceutcials shares in Q1 2026, an estimated $653K.
  • Eton Pharmaceutcials made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4783 holding.
  • Jane Street first reported a position in Eton Pharmaceutcials in Q2 2020 and has held it in 13 quarters since.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.